Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: An analysis of 65,396 hospitalizations from 344 hospitals participating in Get with the Guidelines (GWTG)

American Heart Journal

Volumn 160, Issue 6, 2010, Pages

  Javed, Usman ^a   Deedwania, Prakash C ^a   Bhatt, Deepak L ^b   Cannon, Christopher P ^b   Dai, David ^c   Hernandez, Adrian F ^c   Peterson, Eric D ^c   Fonarow, Gregg C ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORBIDITY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 78650204358     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.08.041     Document Type: Article

References (27)

1. Baigent C., Keech A., and Kearney P.M. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 2005 1267 1278
2. Blazing M.A., De Lemos J.A., and Dyke C.K. The A-to-Z Trial: methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy Am Heart J 142 2001 211 217
3. Cannon C.P., McCabe C.H., and Belder R. Design of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT)-TIMI 22 trial Am J Cardiol 89 2002 860 861
4. de Lemos J.A., Blazing M.A., and Wiviott S.D. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial JAMA 292 2004 1307 1316
5. Cannon C.P., Braunwald E., and McCabe C.H. Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 2004 1495 1504
6. Kinlay S., Schwartz G.G., and Olsson A.G. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study Circulation 108 2003 1560 1566
7. Muhlestein J.B., Horne B.D., and Bair T.L. Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality Am J Cardiol 87 2001 257 261
8. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report Circulation 106 2002 3143 3421
9. Grundy S.M., Cleeman J.I., Merz C.N.B. for the Coordinating Committee of the National Cholesterol Education Program and Endorsed by the National Heart, Lung, and Blood Institute, American College of Cardiology Foundation, and American Heart Association Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines Circulation 110 2004 227 239
10. Antman E.M., Anbe D.T., and Armstrong P.W. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction) J Am Coll Cardiol 44 2004 671 719
11. Braunwald E., Antman E.M., and Beasley J.W. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina) J Am Coll Cardiol 40 2002 1366 1374
12. Sachdeva A., Cannon C.P., and Deedwania P.C. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines Am Heart J 157 2009 111 117.e2
13. Lefer A.M., Campbell B., and Shin Y.K. Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts Circulation 100 1999 178 184
14. Every N.R., Frederick P.D., and Robinson M. A comparison of the national registry of myocardial infarction 2 with the cooperative cardiovascular project J Am Coll Cardiol 33 1999 1886 1894
15. Di Napoli P., and Antonio Taccardi A. Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: an ex vivo study in isolated working rat hearts Cardiovasc Res 51 2001 283 293
16. Fonarow G.C., Wright R.S., and Spencer F.A. Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality Am J Cardiol 96 2005 611 616
17. Gordon T., Castelli W.P., and Hjortland M.C. High density lipoprotein as a protective factor against coronary heart disease: The Framingham Study Am J Med 62 1977 707 714
18. Ko D.T., Alter D.A., and Newman A.M. Association between lipid testing and statin therapy in acute myocardial infarction patients Am Heart J 150 2005 419 425
19. Fyfe T., Baxter R.H., and Cochran K.M. Plasma-lipid changes after myocardial infarction Lancet 2 1971 997 1001
20. Pitt B., Loscalzo J., and Ycas J. Lipid levels after acute coronary syndromes J Am Coll Cardiol 51 2008 1440 1445
21. Mehta R.H., Roe M.T., and Chen A.Y. Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative Arch Intern Med 166 2006 2027 2034
22. Simvastatin with or without ezetimibe in familial hypercholesterolemia N Engl J Med 358 2008 1431 1443
23. Carey J. Do cholesterol drugs do any good? Business Week 2008 52 59
24. Taubes G. What's cholesterol got to do with it? New York Times 2008
25. Greenland P., and Lloyd-Jones D. Critical Lessons From the ENHANCE Trial JAMA 299 2008 953 955
26. Roe M.T., Chen A.Y., and Cannon C.P. Temporal changes in the use of drug-eluting stents for patients with non-ST-segment-elevation myocardial infarction undergoing percutaneous coronary intervention from 2006 to 2008: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines (CRUSADE) and Acute Coronary Treatment and Intervention Outcomes Network-Get With The Guidelines (ACTION-GWTG) Registries Circ Cardiovasc Qual Outcomes 2 2009 414 420
27. Atwater B.D., Oujiri J., and Wolff M.R. The immediate impact of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial on the management of stable angina Clin Cardiol 32 2009 E1 E3